Integral Health Asset Management, LLC
Filing Date
Global Rank
#1,169
/ 8,700
▲ 245
Top Industry
Biotechnology
62.5%
Period ended 2 months ago
Filed Aug 14, 2026 · 30d
26 quarters · since Mar 2020
Portfolio Concentration
90 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
13.3%
+0.5 pts
Top 5
33.1%
−6.0 pts
Top 10
47.0%
−5.0 pts
HHI
377
Diversified−98
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $2,531,730,801 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
24 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| IVA | Inventiva S.A. | +1,120,000 | 1,520,000 | $5,745,600 | |
| CVS | CVS HEALTH Corp | +950,000 | 1,100,000 | $113,795,000 | |
| TNGX | Tango Therapeutics, Inc. | +550,000 | 1,000,000 | $31,260,000 | |
| — | +525,000 | 675,000 | $14,343,750 | ||
| ORIC | Oric Pharmaceuticals, Inc. | +500,000 | 1,900,000 | $20,577,000 | |
| EW | Edwards Lifesciences Corp | +455,000 | 625,000 | $56,537,500 | |
| EWTX | Edgewise Therapeutics, Inc. | +400,000 | 2,000,000 | $81,260,000 | |
| BSX | Boston Scientific Corp | +350,000 | 900,000 | $38,412,000 | |
| ERAS | Erasca, Inc. | +300,000 | 1,000,000 | $18,320,000 | |
| AXSM | Axsome Therapeutics, Inc. | +265,000 | 300,000 | $73,431,000 | |
| SRRK | Scholar Rock Holding Corp | +250,000 | 750,000 | $41,250,000 | |
| NVST | Envista Holdings Corp | +250,000 | 600,000 | $15,810,000 | |
| ACHC | Acadia Healthcare Company, Inc. | +200,000 | 400,000 | $11,812,000 | |
| IONS | Ionis Pharmaceuticals Inc | +175,000 | 300,000 | $23,787,000 | |
| VERA | Vera Therapeutics, Inc. | +150,000 | 1,750,000 | $75,092,500 | |
| DFTX | Definium Therapeutics, Inc. | +150,000 | 550,000 | $25,872,000 | |
| DGX | Quest Diagnostics Inc | +140,000 | 200,000 | $42,390,000 | |
| INSM | INSMED Inc | +100,000 | 1,600,000 | $170,592,000 | |
| LNTH | Lantheus Holdings, Inc. | +65,000 | 190,000 | $21,078,600 | |
| RLMD | Relmada Therapeutics, Inc. | +50,000 | 500,000 | $3,460,000 | |
| BIIB | Biogen Inc. | +40,000 | 100,000 | $21,606,000 | |
| LIVN | LivaNova PLC | +30,000 | 180,000 | $14,801,400 | |
| CAH | Cardinal Health Inc | +30,000 | 300,000 | $71,268,000 | |
| SION | Sionna Therapeutics, Inc. | +25,000 | 75,000 | $3,299,250 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
23 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| RZLT | Rezolute, Inc. | −1,500,000 | 500,000 | $2,600,000 | |
| LFST | LifeStance Health Group, Inc. | −1,300,000 | 3,000,000 | $32,130,000 | |
| SANA | Sana Biotechnology, Inc. | −1,200,000 | 2,000,000 | $6,980,000 | |
| CYTK | Cytokinetics Inc | −1,000,000 | 1,600,000 | $136,304,000 | |
| RVMD | Revolution Medicines, Inc. | −950,000 | 1,800,000 | $337,104,000 | |
| MLYS | Mineralys Therapeutics, Inc. | −800,000 | 450,000 | $12,141,000 | |
| RGNX | REGENXBIO Inc. | −700,000 | 800,000 | $9,584,000 | |
| BTSG | BrightSpring Health Services, Inc. | −700,000 | 550,000 | $38,357,000 | |
| ALHC | Alignment Healthcare, Inc. | −575,000 | 2,000,000 | $47,620,000 | |
| CNC | Centene Corp | −350,000 | 300,000 | $19,257,000 | |
| BHVN | Biohaven Ltd. | −300,000 | 700,000 | $10,416,000 | |
| TARA | Protara Therapeutics, Inc. | −250,000 | 1,500,000 | $5,730,000 | |
| COGT | Cogent Biosciences, Inc. | −150,000 | 200,000 | $7,740,000 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | −100,000 | 200,000 | $16,302,000 | |
| ALMS | Alumis Inc. | −100,000 | 700,000 | $19,698,000 | |
| MRK | Merck & Co., Inc. | −75,000 | 350,000 | $44,975,000 | |
| ASND | Ascendis Pharma A/S | −70,000 | 45,000 | $12,002,400 | |
| OLMA | Olema Pharmaceuticals, Inc. | −50,000 | 100,000 | $1,251,000 | |
| NVS | Novartis AG | −50,000 | 200,000 | $31,344,000 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | −50,000 | 550,000 | $61,066,500 | |
| REGN | Regeneron Pharmaceuticals, Inc. | −45,000 | 40,000 | $24,941,600 | |
| GKOS | GLAUKOS Corp | −25,000 | 150,000 | $20,964,000 | |
| ELV | Elevance Health, Inc. | −25,000 | 50,000 | $19,336,500 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| NVO | Novo Nordisk A S | 900,000 | $43,146,000 | |
| ABT | Abbott Laboratories | 400,000 | $36,296,000 | |
| UNH | Unitedhealth Group Inc | 85,000 | $35,328,550 | |
| THC | Tenet Healthcare Corp | 165,000 | $30,868,200 | |
| SYRE | Spyre Therapeutics, Inc. | 325,000 | $28,853,500 | |
| TVTX | Travere Therapeutics, Inc. | 375,000 | $21,303,750 | |
| MDT | Medtronic plc | 200,000 | $15,646,000 | |
| WAT | Waters Corp /De/ | 40,000 | $15,001,600 | |
| IRTC | iRhythm Holdings, Inc. | 90,000 | $10,705,500 | |
| IART | Integra Lifesciences Holdings Corp | 550,000 | $9,878,000 | |
| GEHC | GE HealthCare Technologies Inc. | 150,000 | $9,601,500 | |
| ABSI | Absci Corp | 800,000 | $9,272,000 | |
| BRKR | Bruker Corp | 150,000 | $9,027,000 | |
| COR | Cencora, Inc. | 30,000 | $8,489,400 | |
| ELVN | Enliven Therapeutics, Inc. | 150,000 | $7,612,500 | |
| BIOA | BioAge Labs, Inc. | 300,000 | $7,353,000 | |
| JAZZ | Jazz Pharmaceuticals plc | 30,000 | $7,229,100 | |
| ALKS | Alkermes plc. | 100,000 | $5,240,000 | |
| KARD | Kardigan, Inc. | 200,000 | $4,770,000 | |
| BNTX | BioNTech SE | 50,000 | $4,652,500 | |
| INSP | Inspire Medical Systems, Inc. | 100,000 | $4,461,000 | |
| TRVI | Trevi Therapeutics, Inc. | 200,000 | $3,730,000 | |
| IDYA | IDEAYA Biosciences, Inc. | 100,000 | $3,727,000 | |
| CLDX | Celldex Therapeutics, Inc. | 100,000 | $3,721,000 | |
| MOBI | Mobia Medical, Inc. | 250,000 | $3,350,000 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
24 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AZN | Astrazeneca PLC | 250,000 | $49,305,000 | |
| FMS | Fresenius Medical Care AG | 775,000 | $17,484,000 | |
| ISRG | Intuitive Surgical Inc | 35,000 | $16,134,650 | |
| TARS | Tarsus Pharmaceuticals, Inc. | 200,000 | $14,030,000 | |
| GILD | Gilead Sciences, Inc. | 100,000 | $13,937,000 | |
| ELAN | Elanco Animal Health Inc | 550,000 | $13,161,500 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 150,000 | $12,588,000 | |
| DXCM | Dexcom Inc | 175,000 | $10,990,000 | |
| IRON | Disc Medicine, Inc. | 170,000 | $10,869,800 | |
| NRIX | Nurix Therapeutics, Inc. | 700,000 | $10,850,000 | |
| COO | Cooper Companies, Inc. | 150,000 | $10,725,000 | |
| TMO | Thermo Fisher Scientific Inc. | 20,000 | $9,830,600 | |
| CELC | Celcuity Inc. | 80,000 | $9,131,200 | |
| SNDX | Syndax Pharmaceuticals Inc | 350,000 | $8,176,000 | |
| VKTX | Viking Therapeutics, Inc. | 250,000 | $8,135,000 | |
| CAPR | Capricor Therapeutics, Inc. | 200,000 | $6,080,000 | |
| IQV | Iqvia Holdings Inc. | 35,000 | $5,968,900 | |
| PTGX | Protagonist Therapeutics, Inc | 50,000 | $5,270,000 | |
| EVMN | Evommune, Inc. | 225,000 | $5,172,750 | |
| ZBH | Zimmer Biomet Holdings, Inc. | 50,000 | $4,521,000 | |
| IMCR | Immunocore Holdings plc | 100,000 | $3,015,000 | |
| MAZE | Maze Therapeutics, Inc. | 100,000 | $2,985,000 | |
| UNCY | Unicycive Therapeutics, Inc. | 225,000 | $1,480,500 | |
| — | 325,000 | $0 | ||
| No positions match the current search. | ||||
90 tracked positions ·
$2,531,730,801 total
· filing declares
92 positions · $2,531,730,300
· as of Jun 30, 2026
Showing 1–50
of 90 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
PUT
+ SHARES
Healthcare
|
Reduced | 1,800,000 | $337,104,000 | 13.32% | |
| INSM |
INSMED Inc
Healthcare
|
Added | 1,600,000 | $170,592,000 | 6.74% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 1,600,000 | $136,304,000 | 5.38% | |
| CVS |
CVS HEALTH Corp
Healthcare
|
Added | 1,100,000 | $113,795,000 | 4.49% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Added | 2,000,000 | $81,260,000 | 3.21% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Added | 1,750,000 | $75,092,500 | 2.97% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Added | 300,000 | $73,431,000 | 2.90% | |
| CAH |
Cardinal Health Inc
Healthcare
|
Added | 300,000 | $71,268,000 | 2.81% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Held | 2,000,000 | $70,780,000 | 2.80% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Reduced | 550,000 | $61,066,500 | 2.41% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Added | 625,000 | $56,537,500 | 2.23% | |
| ALHC |
Alignment Healthcare, Inc.
Healthcare
|
Reduced | 2,000,000 | $47,620,000 | 1.88% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
Reduced | 350,000 | $44,975,000 | 1.78% | |
| NVO |
Novo Nordisk A S
CALL
+ SHARES
Healthcare
|
NEW | 900,000 | $43,146,000 | 1.70% | |
| DGX |
Quest Diagnostics Inc
Healthcare
|
Added | 200,000 | $42,390,000 | 1.67% | |
| QURE |
uniQure N.V.
Healthcare
|
Held | 900,000 | $41,454,000 | 1.64% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Added | 750,000 | $41,250,000 | 1.63% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Added | 900,000 | $38,412,000 | 1.52% | |
| BTSG |
BrightSpring Health Services, Inc.
Healthcare
|
Reduced | 550,000 | $38,357,000 | 1.52% | |
| ABT |
Abbott Laboratories
Healthcare
|
NEW | 400,000 | $36,296,000 | 1.43% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
NEW | 85,000 | $35,328,550 | 1.40% | |
| LFST |
LifeStance Health Group, Inc.
Healthcare
|
Reduced | 3,000,000 | $32,130,000 | 1.27% | |
| NVS |
Novartis AG
Healthcare
|
Reduced | 200,000 | $31,344,000 | 1.24% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Added | 1,000,000 | $31,260,000 | 1.23% | |
| THC |
Tenet Healthcare Corp
Healthcare
|
NEW | 165,000 | $30,868,200 | 1.22% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
NEW | 325,000 | $28,853,500 | 1.14% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
Added | 550,000 | $25,872,000 | 1.02% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Held | 150,000 | $25,281,000 | 1.00% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Reduced | 40,000 | $24,941,600 | 0.99% | |
| IONS |
Ionis Pharmaceuticals Inc
CALL
Healthcare
|
Added | 300,000 | $23,787,000 | 0.94% | |
| BIIB |
Biogen Inc.
Healthcare
|
Added | 100,000 | $21,606,000 | 0.85% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
NEW | 375,000 | $21,303,750 | 0.84% | |
| LNTH |
Lantheus Holdings, Inc.
Healthcare
|
Added | 190,000 | $21,078,600 | 0.83% | |
| GKOS |
GLAUKOS Corp
Healthcare
|
Reduced | 150,000 | $20,964,000 | 0.83% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Added | 1,900,000 | $20,577,000 | 0.81% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Held | 275,000 | $20,482,000 | 0.81% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
Held | 40,000 | $19,869,200 | 0.78% | |
| ALMS |
Alumis Inc.
Healthcare
|
Reduced | 700,000 | $19,698,000 | 0.78% | |
| ELV |
Elevance Health, Inc.
Healthcare
|
Reduced | 50,000 | $19,336,500 | 0.76% | |
| CNC |
Centene Corp
Healthcare
|
Reduced | 300,000 | $19,257,000 | 0.76% | |
| ERAS |
Erasca, Inc.
Healthcare
|
Added | 1,000,000 | $18,320,000 | 0.72% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Held | 15,000 | $17,991,451 | 0.71% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Reduced | 200,000 | $16,302,000 | 0.64% | |
| NVST |
Envista Holdings Corp
Healthcare
|
Added | 600,000 | $15,810,000 | 0.62% | |
| MDT |
Medtronic plc
Healthcare
|
NEW | 200,000 | $15,646,000 | 0.62% | |
| WAT |
Waters Corp /De/
Healthcare
|
NEW | 40,000 | $15,001,600 | 0.59% | |
| LIVN |
LivaNova PLC
Healthcare
|
Added | 180,000 | $14,801,400 | 0.58% | |
|
|
Added | 675,000 | $14,343,750 | 0.57% | ||
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Held | 25,000 | $13,423,750 | 0.53% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Held | 40,000 | $13,391,600 | 0.53% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.